Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP408296.RAhThBRV3D4CZ5v9Q9Skdbng4vv-QSuJGXcPxTeP1Ar3E130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP408296.RAhThBRV3D4CZ5v9Q9Skdbng4vv-QSuJGXcPxTeP1Ar3E130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP408296.RAhThBRV3D4CZ5v9Q9Skdbng4vv-QSuJGXcPxTeP1Ar3E130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP408296.RAhThBRV3D4CZ5v9Q9Skdbng4vv-QSuJGXcPxTeP1Ar3E130_provenance.
- befree-20150227 importedOn "2015-02-27" NP408296.RAhThBRV3D4CZ5v9Q9Skdbng4vv-QSuJGXcPxTeP1Ar3E130_provenance.
- NP408296.RAhThBRV3D4CZ5v9Q9Skdbng4vv-QSuJGXcPxTeP1Ar3E130_assertion wasGeneratedBy ECO_0000203 NP408296.RAhThBRV3D4CZ5v9Q9Skdbng4vv-QSuJGXcPxTeP1Ar3E130_provenance.
- NP408296.RAhThBRV3D4CZ5v9Q9Skdbng4vv-QSuJGXcPxTeP1Ar3E130_assertion wasDerivedFrom befree-20150227 NP408296.RAhThBRV3D4CZ5v9Q9Skdbng4vv-QSuJGXcPxTeP1Ar3E130_provenance.
- NP408296.RAhThBRV3D4CZ5v9Q9Skdbng4vv-QSuJGXcPxTeP1Ar3E130_assertion SIO_000772 19143470 NP408296.RAhThBRV3D4CZ5v9Q9Skdbng4vv-QSuJGXcPxTeP1Ar3E130_provenance.
- NP408296.RAhThBRV3D4CZ5v9Q9Skdbng4vv-QSuJGXcPxTeP1Ar3E130_assertion evidence source_evidence_literature NP408296.RAhThBRV3D4CZ5v9Q9Skdbng4vv-QSuJGXcPxTeP1Ar3E130_provenance.
- NP408296.RAhThBRV3D4CZ5v9Q9Skdbng4vv-QSuJGXcPxTeP1Ar3E130_assertion description "[Therapeutic efficacy of Ad-Flt3L and Ad-TK (+GCV) treatment was demonstrated in a second glioma model and in an intracranial melanoma model with concomitant increases in the levels of circulating HMGB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP408296.RAhThBRV3D4CZ5v9Q9Skdbng4vv-QSuJGXcPxTeP1Ar3E130_provenance.